Position in ORIC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,715,310
-$1,820,514 QoQ
Shares Held
989,410
0.0% QoQ
Ownership
0.955%
of shares outstanding
% of Portfolio
3.48%
of 13F equity value
Holder Rank
#35
of 179 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Euclidean Capital LLC holds $27,571,414 across 6 Biotechnology names. ORIC ranks #1 (38.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORIC |
Oric Pharmaceuticals, Inc.
This page
|
989,410 | $10,715,310 | |
| 2 | FHTX |
Foghorn Therapeutics Inc.
|
1,573,761 | $7,679,953 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
|
2,627,643 | $3,521,041 | |
| 4 | ALEC |
Alector, Inc.
|
1,307,858 | $2,628,794 | |
| 5 | SRZN |
Surrozen, Inc./DE
|
258,529 | $2,275,711 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,015,705 | $750,605 |
All Filings in ORIC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,715,310 | 989,410 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,535,824 | 989,410 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,093,373 | 989,410 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,872,920 | 989,410 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,042,511 | 989,410 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,520,907 | 989,410 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,984,538 | 989,410 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,141,452 | 989,410 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,995,128 | 989,410 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,604,387 | 989,410 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,102,572 | 989,410 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,985,930 | 989,410 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,800,988 | 747,550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,261,035 | 747,550 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,403,069 | 747,550 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,392,160 | 747,550 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,349,024 | 747,550 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,991,917 | 747,550 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,988,985 | 747,550 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,251,105 | 777,193 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,632,224 | 996,734 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $24,419,983 | 996,734 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $47,404,724 | 1,400,435 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||